Sinclair Pharma Plc (Sinclair) is a public company operating as a global specialty pharmaceutical company that focuses on developing pharmaceuticals in the therapeutic areas of dermatology, wound care and oral health. It has almost 20 products registered in EU, 11 in the US and a strong pipeline. In addition, the company is developing products in gynaecology. Sinclair acquired two major dermatology products, Flammazine and Flammacerium, from Solvay Pharmaceuticals in October, 2009 for a total consideration of €17.5 million. The company caters its products to over 40 countries present in France, UK, Italy, Spain and Portugal. Sinclair is headquartered in Surrey, England, the United Kingdom.

Street: 
Godalming Business Centre
City: 
Surrey
Postcode: 
GU7 1XW
Federal State : 
United Kingdom
WebSite: 
www.sinclairpharma.com
Fax: 
44-1483-410620

Company Index Score

Current Index Score Historical Index Score
  • Sinclair Pharma Plc currently scores 50 % in the index.
  • Sinclair Pharma Plc is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Sinclair Pharma Plc is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets